Language Select
Varian Logo

INVESTOR RELATIONS

 

Varian Expands Cancer Care Solutions Portfolio with Interventional Oncology Acquisitions

Tuesday, June 11, 2019
6:45am PST

Listen to Webcast
Presentation
To Access the Call:
877-407-9708 / 201-689-8259

Varian to Discuss Agreement to Acquire Cancer Treatment Services International

Tuesday, May 21, 2019
8:00am EST

Listen to the Webcast
Presentation
Press Release
To Access the Call:
Inside the U.S.: 1-877-407-9708 / Outside the U.S.: 1-201-689-8259
Replay:
Inside the U.S.: 1-877-660-6853 / Outside the U.S.: 1-201-612-7415
Use Conference ID 13691221

2019 UBS Global Healthcare Conference

Tuesday, May 21, 2019
9:00am EST

Listen to the Webcast

2019 RBC Capital Markets Global Healthcare Conference

Wednesday, May 22, 2019
9:30am EST

Listen to the Webcast

Recent News
Jun 17, 2019

Varian (NYSE: VAR) today announced it has successfully completed its acquisition of Cancer Treatment Services International (CTSI). There were no changes during the closing period to the original...

Jun 13, 2019

Varian (NYSE: VAR) today announced it will be delivering presentations focused on artificial intelligence (AI), federated data sources and clinical decision support at the 19th International...

Jun 12, 2019

Varian (NYSE: VAR) today announced the Proton Clinical Research Center of the Shandong Cancer Hospital, is the first center in Asia Pacific to join the FlashForward™ Consortium. The Consortium...

More news >


Contact Investor Relations

Varian Corporate Headquarters
Tel: 650-424-5631
E-mail: investors@varian.com
IR Contacts

NYSE: VAR
NYSEVAR
  • Follow Us

Production of any of the material contained herein in any format or media without the express written permission of Varian Medical Systems is prohibited.

Varian Logo